ArticleResuscitation plus2026
Mochi-related vs other food-related foreign body airway obstruction: outcomes from the MOCHI registry.
Article in Resuscitation plus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Mochi (Japanese rice cake) is frequently implicated in severe foreign body airway obstruction (FBAO) due to its distinctive viscoelasticity and adhesive properties. However, it remains unclear whether mochi-related FBAO is associated with worse outcomes. Methods: In this nationwide prospective multicenter observational study (MOCHI registry), we analyzed patients with food-related FBAO transported to hospitals. The exposure was mochi-related FBAO and the comparator was other food-related FBAO. The primary outcome was 30-day survival; secondary outcome included favorable neurological outcome (Cerebral Performance Category [CPC] 1-2). We employed inverse probability of treatment weighting (IPTW) based on a propensity score model including age, sex, baseline functional status, comorbidities, event setting, witness status, and the New Year period. Results: Of 409 patients assessed for eligibility in the MOCHI registry, 399 were included in the final analysis; 63 (15.8%) presented with mochi-related FBAO. Mochi cases were more often ADL-independent (44/61 [72.1%] vs 128/329 [38.9%]) and had fewer comorbidities (e.g., dementia: 10/63 [15.9%] vs 116/336 [34.5%]; prior stroke: 5/63 [7.9%] vs 74/336 [22.0%]) and clustered at home during the New Year period. In the IPTW analysis, mochi was not significantly associated with 30-day survival (IPTW-weighted OR, 0.93; 95% CI, 0.41-2.11) or favorable neurological outcomes (IPTW-weighted OR, 0.87; 95% CI, 0.30-2.49). Conclusions: Mochi was not statistically significantly associated with 30-day outcomes after adjustment, but estimates were imprecise. Mochi-related events occurred disproportionately among relatively healthier, functionally independent individuals and occurred predominantly at home during seasonal consumption, supporting targeted seasonal prevention and public education in home settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.